Document Detail


Single intravenous injection of plasmid DNA encoding human paraoxonase-1 inhibits hyperlipidemia in rats.
MedLine Citation:
PMID:  20580687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Paraoxonase-1 (PON1, EC 3.1.8.1) is a high-density lipoprotein (HDL)-associated antioxidant enzyme, and its activity correlates negatively with the level of plasma low-density lipoprotein cholesterol (LDL-C) and triglyceridemia (TG). In this study, we examined the therapeutic effect of plasmid DNA containing the human PON1 gene (pcDNA/PON1) in hyperlipidemic model rats. The rats were fed a high-fat and high-cholesterol diet for 25 days to produce a hyperlipidemic animal model. Single intravenous injection of pcDNA/PON1 into model rats prevented dyslipidemia and hepatic lipid accumulation. The mechanisms of pcDNA/PON1 in treating hyperlipidemia were associated with increases of serum antioxidant PON1 and SOD activities, and with reduction of the levels of total cholesterol (TC), LDL-C and TG. The results suggest the potential therapeutic effect of pcDNA/PON1 on hyperlipidemia.
Authors:
Ai Ling Fu; Shao Ping Wu
Related Documents :
11372707 - Metabolic studies on lean and fat pekin ducks selected for breast muscle thickness meas...
22243657 - Reducing sodium levels in frankfurters using naturally brewed soy sauce.
9323587 - Clearance of postprandial and lipolytically modified human hdl in rabbits and rats.
16829397 - Interrelations between lipoprotein and the elimination of exogenous triglycerides from ...
15649137 - The conflicting role of brain cholesterol in alzheimer's disease: lessons from the brai...
1121487 - Effect of cholestyramine on tissue pools of cholesterol a preliminary report.
Publication Detail:
Type:  Journal Article     Date:  2010-05-24
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  397     ISSN:  1090-2104     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  257-62     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
School of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. A.L.Fu@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aryldialkylphosphatase / blood,  genetics*
Cholesterol, LDL / blood
DNA / administration & dosage*
Gene Therapy / methods*
Humans
Hyperlipidemias / therapy*
Injections, Intravenous
Liver / metabolism
Male
Plasmids / administration & dosage
Rats
Rats, Sprague-Dawley
Superoxide Dismutase / blood
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Cholesterol, LDL; 0/Triglycerides; 9007-49-2/DNA; EC 1.15.1.1/Superoxide Dismutase; EC 3.1.8.1/Aryldialkylphosphatase; EC 3.1.8.1/PON1 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urokinase receptor (uPAR) regulates complement receptor 3 (CR3)-mediated neutrophil phagocytosis.
Next Document:  Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor...